Received Jul 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 1 | — | IM / LA |
Cellulitis at injection site (Left Deltoid). Warm, erythematous, painful welp formed within 24 hours of injection. Warmth and erythema spread with poorly defined borders down to antecubital region. Augmentin started. Ongoing treatment.
N/A
N/A
N/A
NKDA/NKA